Kobayashi Pharmaceutical Co. on Feb. 10 posted its first full-year profit decline since going public in 1999 as the health ...

The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

President Volodymyr Zelenskyy has put into effect the decision of the National Security and Defense Council (NSDC) of ...

USF women's lacrosse makes its historic debut Friday, Feb. 7 at Corbett Stadium. As the inaugural team, the players are well ...

Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...

A recent pause in U.S. sales of Varipulse is hampering the company’s bid to catch up in one of the industry’s fastest-growing ...

Major indices on the Wall Street were little changed on Friday as investors tried to make sense of the latest job figures and ...

London stocks ended Thursday in mixed territory as investors assessed a fall in jobless claims across the pond, as well as an unexpected expansion in the UK economy.

Welcome to Industrials Regulatory News and Trends. In this regular bulletin, DLA Piper lawyers provide concise updates on key developments in ...

The three are Doug Renfro, her cousin who handles marketing, and James, her brother who is in charge of production. Since ...

It was then that the Children’s Hospital of Orange County in California sought special permission to use an experimental drug — Zaynich — developed by Indian pharmaceutical company ... allowing ...

In response to US President Donald Trump's recent executive orders imposing tariffs on Canada, China and Mexico, these countries have retaliated with their own actions. President Trump signed an ...